SR-9009 increases metabolism, fat burning, and muscle growth.
Though SR-9009 resembles and is associated with SARMs, SR-9009 is a Rev-Erb developed Sripps Research Institute (TSRI) by Professor Thomas Burris and his team, also known as stenabolic. It is a unique compound with the ability to affect a wide range of mechanisms in the body such as fat storage, circadian rhythms, and glucose metabolism. It is due to these effects that SR-9009 is said to show great promise to treat conditions such as obesity, congestive heart failure, chronic obstructive pulmonary disease (COPD) and prevent age-related muscle deterioration.
Stenabolic (SR-9009) works by stimulating the Rev-Erb protein. Therefore, it triggers various processes in the body. Most importantly, it causes an increase in mitochondrial count in the muscles and enhances metabolism. Therefore, the user notices a drastic improvement in muscle strength and endurance. Mice subjects used during the trials could run 50% extra in terms of time and distance when SR-9009 was administered.
These results imply that less fat is stored in the body, the liver develops less cholesterol and muscle strength is enhanced due to increased fat and glucose metabolism. SR9009 possesses great potential in the medical field such as treating type 2 diabetes and obesity especially in individuals who cannot exercise or train to lose weight.
SR-9009 can also be a breakthrough in the fitness world since it promises to work wonders in enhancing endurance, increasing strength, muscle growth, fat loss and decreasing blood sugar levels. Therefore, athletes can do more cardio training, lift more weight, gain leaner muscles while losing fat and improving cholesterol and blood sugar levels. Can be used solo or stacked.